Literature DB >> 29911818

The opioid crisis in Canada: a national perspective.

Lisa Belzak1, Jessica Halverson1.   

Abstract

INTRODUCTION: This review provides a national summary of what is currently known about the Canadian opioid crisis with respect to opioid-related deaths and harms and potential risk factors as of December 2017.
METHODS: We reviewed all public-facing opioid-related surveillance or epidemiological reports published by provincial and territorial ministries of health and chief coroners' or medical examiners' offices. In addition, we reviewed publications from federal partners and reports and articles published prior to December 2017. We synthesized the evidence by comparing provincial and territorial opioid-related mortality and morbidity rates with the national rates to look for regional trends.
RESULTS: The opioid crisis has affected every region of the country, although some jurisdictions have been impacted more than others. As of 2016, apparent opioid-related deaths and hospitalization rates were highest in the western provinces of British Columbia and Alberta and in both Yukon and the Northwest Territories. Nationally, most apparent opioid-related deaths occurred among males; individuals between 30 and 39 years of age accounted for the greatest proportion. Current evidence suggests regional age and sex differences with respect to health outcomes, especially when synthetic opioids are involved. However, differences between data collection methods and reporting requirements may impact the interpretation and comparability of reported data.
CONCLUSION: This report identifies gaps in evidence and areas for further investigation to improve our understanding of the national opioid crisis. The Public Health Agency of Canada will continue to work closely with the provinces, territories and national partners to further refine and standardize national data collection, conduct special studies and expand information-sharing to improve the evidence needed to inform public health action and prevent opioid-related deaths and harms.

Entities:  

Keywords:  Canada; crisis; deaths; fentanyl; harms; opioid; overdose

Mesh:

Substances:

Year:  2018        PMID: 29911818      PMCID: PMC6034966          DOI: 10.24095/hpcdp.38.6.02

Source DB:  PubMed          Journal:  Health Promot Chronic Dis Prev Can        ISSN: 2368-738X            Impact factor:   3.240


  1 in total

1.  Deaths related to the use of prescription opioids.

Authors:  Benedikt Fischer; Jürgen Rehm
Journal:  CMAJ       Date:  2009-12-07       Impact factor: 8.262

  1 in total
  75 in total

1.  Emergency Department Initiation of Buprenorphine for Opioid Use Disorder: Current Status, and Future Potential.

Authors:  Lindsay Fox; Lewis S Nelson
Journal:  CNS Drugs       Date:  2019-12       Impact factor: 5.749

2.  Initiation and Rapid Titration of Methadone in an Acute Care Setting for the Treatment of Opioid Use Disorder: A Case Report.

Authors:  Patrick Hemmons; Paxton Bach; Kate Colizza; Seonaid Nolan
Journal:  J Addict Med       Date:  2019 Sep/Oct       Impact factor: 3.702

3.  A new hypertonic saline assay for analgesic screening in mice: effects of animal strain, sex, and diurnal phase.

Authors:  Yahya I Asiri; Desmond H Fung; Timothy Fung; Alasdair M Barr; Ernest Puil; Stephan K W Schwarz; Bernard A MacLeod
Journal:  Can J Anaesth       Date:  2021-02-18       Impact factor: 5.063

4.  Commentary - Building the evidence base for sustained public health response to the opioid epidemic in Canada.

Authors:  Theresa Tam
Journal:  Health Promot Chronic Dis Prev Can       Date:  2018-06       Impact factor: 3.240

5.  Injuries and poisonings associated with methamphetamine use: sentinel surveillance, the electronic Canadian Hospitals Injury Reporting and Prevention Program (eCHIRPP), 2011-2019.

Authors:  Steven R McFaull; André Champagne; Wendy Thompson; Felix Bang
Journal:  Health Promot Chronic Dis Prev Can       Date:  2020-04       Impact factor: 3.240

6.  Pharmaceutical opioids utilisation by dose, formulation, and socioeconomic status in Queensland, Australia: a population study over 22 years.

Authors:  Adeleke D Adewumi; Joemer C Maravilla; Rosa Alati; Samantha A Hollingworth; Xuelei Hu; Bill Loveday; Jason P Connor
Journal:  Int J Clin Pharm       Date:  2020-09-23

7.  Donation after circulatory determination of death in western Canada: a multicentre study of donor characteristics and critical care practices.

Authors:  Andreas H Kramer; Kerry Holliday; Sean Keenan; George Isac; Demetrios J Kutsogiannis; Norman M Kneteman; Adrian Robertson; Peter Nickerson; Lee Anne Tibbles
Journal:  Can J Anaesth       Date:  2020-02-25       Impact factor: 5.063

8.  Psychiatry and the Opioid Crisis in Canada.

Authors:  Grainne E Neilson; Alison Freeland; Christian G Schütz
Journal:  Can J Psychiatry       Date:  2019-11-18       Impact factor: 4.356

9.  Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky.

Authors:  Hannah Lf Cooper; David H Cloud; Patricia R Freeman; Monica Fadanelli; Travis Green; Connor Van Meter; Stephanie Beane; Umedjon Ibragimov; April M Young
Journal:  Int J Drug Policy       Date:  2020-03-26

10.  People, places, and stigma: A qualitative study exploring the overdose risk environment in rural Kentucky.

Authors:  Monica Fadanelli; David H Cloud; Umedjon Ibragimov; April M Ballard; Nadya Prood; April M Young; Hannah L F Cooper
Journal:  Int J Drug Policy       Date:  2019-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.